Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:13 AM ET 8-K
Leadership Change MeiraGTx Holdings plc MGTX

MeiraGTx Holdings Leadership Change

MeiraGTx Holdings plc appointed Alan M. Sebulsky to its Board of Directors as a Class I director, effective September 23, 2026. Mr. Sebulsky, a veteran healthcare portfolio manager with over 40 years of experience, will also serve on the company's Science and Technology Committee.

Counterparty
Alan M. Sebulsky
8:09 AM ET Form 4
Insider Selling Robinhood Markets, Inc. HOOD

Robinhood Markets CEO Vladimir Tenev Sells $32.5M of Stock

Vladimir Tenev, CEO, sold 259,166 shares of Robinhood Markets, Inc. at $125.55 to $126.15 a share (average $125.58) in 2 transactions, worth $32.5M in total on Sep 21, 2026. Shares held after the trade: 0 (-100.0%).

Value
$32.5M
Shares
259,166
Average price
$125.58
Role
CEO
Holding change
-100.0%
Trade date
Sep 21, 2026
8:07 AM ET 8-K
Leadership Change IIOT-OXYS, Inc. ITOX

IIOT-OXYS Leadership Change

IIOT-OXYS, Inc. appointed Vidhyadhar Mitta to its Board of Directors, effective September 21, 2026. Mr. Mitta previously served as a director for the company and has a history of financial involvement, including a 2025 debt exchange agreement where he converted $216,156 of debt into Series E Preferred Stock.

Counterparty
Vidhyadhar Mitta
8:06 AM ET 8-K
Investor Presentation Astrana Health, Inc. ASTH

Astrana Health Investor Presentation

Astrana Health, Inc. has updated its corporate investor presentation for use in upcoming conferences and meetings. The presentation includes strategic highlights and forward-looking information regarding the company's business operations and financial objectives.

8:04 AM ET 8-K
Loan & Debt Beyond Meat, Inc. BYND

Beyond Meat $15M Debt Financing

Beyond Meat entered into privately negotiated exchange agreements to retire $15.0 million in principal of its 0% Convertible Senior Notes due 2027. The company is exchanging the debt at 96% of its face value for shares of common stock, with an initial issuance of 1,097,444 shares and a potential 'true up' issuance of up to 848,265 additional shares based on a three-day VWAP calculation.

Value
$15M
8:04 AM ET 8-K
Investor Presentation Knife River Corp KNF

Knife River Investor Presentation

Knife River Corporation filed a formal investor presentation deck (Exhibit 99.1) for its September 2026 conference activities. The presentation outlines the company's long-term investment thesis, market dynamics, and strategic 'EDGE' initiatives focused on margin improvement and vertical integration.

8:01 AM ET 8-K
Other 8-K Filing Adagio Medical Holdings, Inc. ADGM

Adagio Medical Holdings Other 8-K Filing

Adagio Medical Holdings has initiated a formal process to explore strategic alternatives, including a potential merger or sale, to maximize shareholder value. In connection with this review, the company is reducing its workforce by 58% (25 of 43 employees) and expects to incur $1.3 million in cash expenditures for severance and related costs. Additionally, the company is lowering the conversion price for its 13% Senior Secured Convertible Notes through October 31, 2026, to facilitate potential debt conversions.

8:01 AM ET 8-K
Investor Presentation Mcdonalds Corp MCD

Mcdonalds Investor Presentation

McDonald's Corporation announced its new 'McDonald’s > NEXT' strategy, detailing long-term growth and productivity targets through 2030. The company aims to gain 1.5 percentage points of market share in chicken and beverages, expand operating margins to the low-to-mid 50% range, and achieve 250 basis points of restaurant-level efficiency gains.

8:01 AM ET 8-K
Nasdaq/NYSE Compliance Notice Lakeshore Acquisition III Corp. LCCC

Lakeshore Acquisition III Nasdaq/NYSE Compliance Notice

Lakeshore Acquisition III Corp. received approval from Nasdaq to transfer the listing of its units, ordinary shares, and rights from the Nasdaq Global Market to the Nasdaq Capital Market. The transfer is effective at the opening of business on September 24, 2026, and the securities will continue to trade under their existing symbols (LCCCU, LCCC, and LCCCR).

Counterparty
Nasdaq
8:00 AM ET 8-K
Leadership Change Valion Bio, Inc. VBIO

Valion Bio Leadership Change

Valion Bio, Inc. appointed Dean Zikria as Interim Chief Executive Officer, effective September 22, 2026, succeeding Sheryle Bolton who stepped down from the Board. Mr. Zikria, an existing director, will receive a monthly consulting fee of $23,333 and up to 100,000 restricted stock units as part of his interim leadership agreement.

8:00 AM ET 8-K
Shareholder Meeting Saratoga Investment Corp. SAR

Saratoga Investment Shareholder Meeting

Saratoga Investment Corp. held its 2026 Annual Meeting of Stockholders on September 22, 2026. Shareholders elected G. Cabell Williams and Henri J. Steenkamp to the board of directors and ratified the selection of Ernst & Young LLP as the company's independent accounting firm for the fiscal year ending February 28, 2026.

7:46 AM ET 8-K
Investor Presentation Lantern Pharma Inc. LTRN

Lantern Pharma Investor Presentation

Lantern Pharma is hosting a live webinar and investor presentation to discuss the growth plan, development roadmap, and economics of its wholly owned subsidiary, Open-Medicine AI. The session will include a live demonstration of the multi-agentic AI platform's capabilities and an overview of the subscription and enterprise licensing model.

Earnings call
Sep 23, 2026, 12:30 PM ET
7:36 AM ET 8-K
Other 8-K Filing Beneficient BENF

Beneficient Other 8-K Filing

Beneficient announced a comprehensive strategy to eliminate approximately $130 million in fraudulent debt asserted by HCLP Nominees and $850 million in preferred equity interests held by former CEO Brad Heppner following his federal fraud conviction. The company is seeking a consensual resolution to convert Heppner's massive equity stake into just 162,132 Class A shares and terminate all remaining agreements to simplify its capital structure. If a resolution is not reached before Heppner's October 2026 sentencing, the company intends to pursue litigation to void the obligations and interests.

Counterparty
Brad Heppner
7:31 AM ET 8-K
Nasdaq/NYSE Compliance Notice Cytosorbents Corp CTSO

Cytosorbents Nasdaq/NYSE Compliance Notice

CytoSorbents has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its stock closed at or above that level for 10 consecutive trading sessions. However, the company remains non-compliant with the $35 million Minimum Market Value of Listed Securities (MVLS) requirement and has until December 28, 2026, to resolve this deficiency.

Counterparty
Nasdaq
Term
until Dec 28, 2026
7:30 AM ET 8-K
Financial Results Cracker Barrel Old Country Store, Inc CBRL

Cracker Barrel Old Country Store Financial Results

Cracker Barrel reported Q4 fiscal 2026 total revenue of $849.3 million and GAAP net income of $12.2 million, reflecting a 2.2% revenue decrease year-over-year. During the quarter, the company reduced total debt to $337.2 million following a $150 million note repayment and a $77 million sale-leaseback transaction involving 26 store locations.

Term
Q4 2026
Earnings call
Sep 23, 2026, 8:15 AM ET

“I’m honored to lead such a differentiated and iconic brand. The Company is focused on the right areas and has a strong plan, as demonstrated by the continued improvements in the underlying traffic trend, key guest metrics, and EBITDA results. I am excited about the opportunity ahead and confident that our strategic priorities around food, experience, and people will sustain this momentum and drive long-term value creation.”

David Deno, President and Chief Executive Officer
7:30 AM ET 8-K
Cybersecurity Incident Astrana Health, Inc. ASTH

Astrana Health Cybersecurity Incident

Astrana Health disclosed a material cybersecurity incident involving social engineering and unauthorized access to its systems by threat actors impersonating company personnel. The company determined the incident is material as of September 22, 2026, due to the potential compromise of sensitive patient, employee, and provider data. Remedial actions including credential resets and system restorations have been implemented while a forensic investigation remains ongoing.

7:30 AM ET 8-K
Business Update Anteris Technologies Global Corp. AVR

Anteris Technologies Global Business Update

Anteris Technologies Global Corp. entered into an amendment to its existing Supply & Quality Agreement with Harvey Industries Group Pty Ltd. The amendment extends the contract term until December 31, 2026, or until a new replacement agreement is executed, ensuring continued operational supply for the company's subsidiary.

Counterparty
Harvey Industries Group Pty Ltd
Term
through Dec 2026
7:15 AM ET 8-K
Product Launch SharonAI Holdings Inc. SHAZ

SharonAI Holdings Product Launch

SharonAI Holdings announced a collaboration with VAST Data to launch DataEnclave, a confidential AI capability integrated into Sharon AI's AI Factory platform across Australia and Asia-Pacific. The service provides a hardware-isolated secure runtime for running advanced AI models onshore, allowing regulated organizations like banks and government agencies to process sensitive data without it leaving their controlled infrastructure.

Counterparty
VAST Data

“Our customers across Australia and Asia-Pacific need to run AI at full speed without compromising on data sovereignty, and increasingly they also want access to frontier models that were previously only available offshore. Building on our sovereign data foundation with VAST DataEnclave is expected to let us host those models onshore, inside attested environments where the model owner’s weights and the customer’s data are both protected from everyone, including us.”

James Manning, Co-founder and Chief Executive Officer
7:13 AM ET 8-K
Business Update Ivanhoe Electric Inc. IE

Ivanhoe Electric Business Update

Ivanhoe Electric released an updated S-K 1300 Preliminary Feasibility Study (PFS) for its Santa Cruz Copper Project in Arizona. The report replaces the previous 2025 study and provides updated technical and economic assumptions for the project's development. The company is hosting an investor call and slideshow presentation to discuss the results of the study.

7:11 AM ET 8-K
Business Update Armata Pharmaceuticals, Inc. ARMP

Armata Pharmaceuticals Business Update

Armata Pharmaceuticals received $3.7 million in additional non-dilutive funding from the U.S. Department of War to support the Phase 3 development of its AP-SA02 bacteriophage candidate. This incremental funding brings the total cumulative government support for the program to $32.4 million and is intended to fund activities for a pivotal superiority study in complicated S. aureus bacteremia.

Counterparty
U.S. Department of War
7:02 AM ET 8-K
Financial Results General Mills Inc GIS

General Mills Financial Results

General Mills reported fiscal 2027 first-quarter net sales of $4.4 billion, a 3% decrease primarily due to the divestiture of its U.S. yogurt business. Adjusted diluted EPS fell 13% in constant currency to $0.75, while the company reaffirmed its full-year outlook despite a volatile operating environment.

Term
Q1 2027
Earnings call
Sep 23, 2026, 9:00 AM ET

“We are off to an encouraging start in fiscal 2027, driving improved topline performance with stronger product innovation and renovation focused on the benefits consumers are looking for today.”

Jeff Harmening, General Mills Chairman and Chief Executive Officer

“We are also executing with discipline in a volatile environment, including delivering industry-leading cost savings through our Holistic Margin Management program and our global Transformation initiative. Based on our progress and the actions underway, we remain confident in our ability to deliver our fiscal 2027 guidance.”

Jeff Harmening, General Mills Chairman and Chief Executive Officer
7:00 AM ET Form 4
Insider Buying Agree Realty Corp ADC

Agree Realty Chief Growth Officer Craig Erlich Buys $67.5K of Stock

Craig Erlich, Chief Growth Officer, bought 1,000 shares of Agree Realty Corp at $67.55 a share, worth $67.5K in total on Sep 21, 2026. Shares held after the trade: 60,388 (+1.7%).

Value
$67.5K
Shares
1,000
Price
$67.55
Role
Chief Growth Officer
Holding change
+1.7%
Trade date
Sep 21, 2026
6:40 AM ET 8-K
Leadership Change Angi Inc. ANGI

Angi Leadership Change

Angi Inc. appointed Michael Steib as Chief Executive Officer, succeeding Jeffrey W. Kip who stepped down from the role and the Board effective September 22, 2026. Additionally, Joseph Levin transitioned from Executive Chairman to Chairman of the Board, and the Board size was reduced to nine members.

6:06 AM ET Form 4
Insider Selling Keysight Technologies, Inc. KEYS

Keysight Technologies EVP and CFO Neil Dougherty Sells $682K of Stock

Neil Dougherty, EVP and CFO, sold 2,000 shares of Keysight Technologies, Inc. at $340.79 a share, worth $682K in total on Sep 21, 2026. Shares held after the trade: 123,390 (-1.6%).

Value
$682K
Shares
2,000
Price
$340.79
Role
EVP and CFO
Holding change
-1.6%
Trade date
Sep 21, 2026
6:05 AM ET Form 4
Insider Selling KE Holdings Inc. BEKE

KE Holdings Executive Director Yigang Shan Sells $18.1M of Stock

Yigang Shan, Executive Director, sold 3,326,670 shares of KE Holdings Inc. at $5.44 a share, worth $18.1M in total on Sep 21, 2026. Shares held after the trade: 53,868,189 (-5.8%).

Value
$18.1M
Shares
3,326,670
Price
$5.44
Role
Executive Director
Holding change
-5.8%
Trade date
Sep 21, 2026
6:03 AM ET 8-K
Clinical Trial Data Ionis Pharmaceuticals Inc IONS

Ionis Pharmaceuticals Clinical Trial Data

Ionis and partner Roche announced positive interim results from the Phase 3 IMAgINATION study of sefaxersen in adults with IgA nephropathy (IgAN). The study met its primary endpoint, demonstrating statistically significant and clinically meaningful reductions in proteinuria compared to placebo at 37 weeks.

Counterparty
Roche Holding Ltd.

“With these positive interim results, sefaxersen is positioned to directly address a primary driver of IgAN-related kidney damage, offering the potential to help slow disease progression and potentially reduce the long-term need for dialysis or kidney transplantation.”

Brett P. Monia, Ph.D., chief executive officer, Ionis
6:03 AM ET 8-K
M&A Deal Royal Caribbean Cruises Ltd RCL

Royal Caribbean Cruises Signs $3B M&A Deal with Sandals and Beaches Resorts

Royal Caribbean Cruises Ltd. has entered into a definitive agreement to acquire a 50% equity interest in Sandals and Beaches Resorts for approximately $3.0 billion in cash. The transaction, funded by committed debt financing from Morgan Stanley, expands Royal Caribbean's vacation platform into the all-inclusive resort space and is expected to close in early 2027.

Value
$3B
Counterparty
Sandals and Beaches Resorts
6:03 AM ET 8-K
Business Update Artificial Intelligence Technology Solutions Inc. AITX

Artificial Intelligence Technology Solutions Business Update

Artificial Intelligence Technology Solutions' subsidiary, RAD, received its third order from national dealer Third Order within seven weeks. The order includes two RIO Mini systems and one AVA unit to support security operations for a major construction equipment company in North Carolina. This update highlights the expanding product mix and market reach of RAD's AI-driven security portfolio across different end-user settings.

Counterparty
Third Order
6:03 AM ET 8-K
Leadership Change Boston Scientific Corp BSX

Boston Scientific Leadership Change

Arthur C. Butcher, Executive Vice President and Group President of MedSurg and Asia Pacific, has announced his retirement effective January 1, 2027. He will serve as a senior advisor through February 26, 2027, maintaining his current annual base salary of $780,000 during the transition period.

6:03 AM ET Form 4
Insider Selling Sea Ltd SE

Sea CCO and GC Yanjun Wang Sells $247K of Stock

Yanjun Wang, CCO and GC, sold 2,400 shares of Sea Ltd at $100.69 to $103.80 a share (average $102.75) in 5 transactions, worth $247K in total between Sep 21, 2026 and Sep 22, 2026. Shares held after the trade: 96,380 (-0.9%).

Value
$247K
Shares
2,400
Average price
$102.75
Role
CCO and GC
Holding change
-0.9%
Trade date
Sep 21, 2026 to Sep 22, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.